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Meeting Report
EMBO Workshop: Membrane Contact
Sites in Health and Disease
Emmanuelle M. Bayer1, Tito Calı̀2,3 , Francesca Giordano4,
Anne Hamacher-Brady5 and Luca Pellegrini6
The key evolutionary innovation of the Last Eukaryotic
Common Ancestor consisted in the formation of physi-
cally and functionally specialized organelles that, through
the compartmentalization of biological processes and sig-
naling pathways, allowed life to adapt to new challenging
and ever-changing environments. Similarly, the basic
drive of the evolution of the eukaryotic cell consisted in
using sites of contact between organelles as a platform for
hosting biological or regulatory processes, thereby allow-
ing life to evolve complexity through tissue and cellular
specialization. For this reason, in the past decade, the
study of interorganellar associations has attracted great
interest and momentum. The emerging picture is one
where organelles establish multiple and physically close
or direct contacts with each other (Figure 1), through the
activity of protein tethering complexes. This association,
in turn, creates a spatially and functionally specialized
subcellular compartment known as membrane contact
sites (MCS); here, dedicated protein complexes allow
MCS to execute and coordinate a plethora of physiolog-
ical, metabolical, and cellular processes.
The discovery of MCS forced cell biologists to pro-
foundly reconsider the way organelles are studied because
it introduced the concept that through a network of spe-
cialized membranes, organelles can control, and interact
and cooperate with each other, thereby allowing for the
orchestration of integrated and novel functions that indi-
vidual organelles would otherwise be unable to perform. It
is now clear that complex processes indeed occur at the
interface between the endoplasmic reticulum (ER) and
mitochondria, Golgi, endosomes, peroxisomes, lipid drop-
lets, and the plasma membrane (PM). Moreover, hetero-
typic contact sites between other types of organelles also
exist; they include, for instance, those between mitochon-
dria and peroxisomes or endosomes/lysosomes (vacuole in
yeast) or between PM and endosomes/lysosomes. Their
ultrastructural and functional characterization has just
started to emerge in the literature and at scientificmeetings.
The parallel discovery of new types of MCS and of
their role in key physiological and metabolic processes
prompted a new community of cell biologists to emerge
and to come together to work on two key objectives.
One was that of launching a new scientific journal ded-
icated to becoming the gold-standard journal in this
field: Contact. Under the leadership of Tim Levine
(University College London, UK), Contact aims at
addressing how MCS mediate and regulate cellular
homeostasis and how impaired MCS biogenesis, regula-
tion, or activity are linked to human diseases and meta-
bolic conditions. The second objective was that of
organizing and promoting the MCS field through the
organization of world-class scientific meetings. So,
under the leadership of Luca Scorrano (University of
Padua, Italy), the very first meeting on MCS took
place as an EMBO Workshop in Domus Maria, Italy,
from September 15 to 18, 2016. Following the immense
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success of that meeting, under the leadership of Thomas
Simmen (University of Alberta, Canada), new exciting
insights and key questions about MCS biology were
recently discussed at the EMBO Workshop on
“Membrane Contact Sites in Health and Diseases.”
This conference was co-organized by Jennifer Rieusset
(University of Lyon, France), Antonio Zorzano (IRB,
Spain), and Stephan Frank (University of Basel,
Switzerland) and was held in the beautiful mountains
of Arosa, Switzerland, from September 21 to 25, 2018.
It gathered more than 120 MCS scholars from all
over the world who presented a wealth of mostly still
unpublished studies. What follows here is a report of
the entirety of the talks, and selected posters, that were
presented and discussed at this EMBO Workshop.
The Wilhelm Bernhard Prize and the
Keynote Lecture
The meeting opened by awarding Prof. Jean Vance
(University of Alberta, Canada) the Wilhelm Bernhard
Prize in MCS biology. Jean pioneered the MCS field
by discovering and functionally characterizing the
mitochondria-associated ER membranes (MAMs), also
known as mitochondria-ER contact sites (MERCs), in
phospholipids biosynthesis. Indeed, in the 90s, her labo-
ratory successfully isolated this subcellular structure and
showed that phosphatidylserine (PS) is imported into
mitochondria from the ER via the MAM/MERCs for
decarboxylation to phosphatidylethanolamine (PE). Her
captivating award lecture thus focused on these and
related groundbreaking milestones in the MCS field.
The EMBO Workshop opening keynote was held by
Prof. Kai Simons (Max Planck Institute for Molecular
Cell Biology and Genetics and Lipotype GmbH,
Germany) who presented a fascinating overview of
how lipid biology and the use of lipidomics analysis
can continue to drive the functional and structural char-
acterization of new types of MCS. Lipids are important
building blocks of life. Their main function is to form the
matrix of our cell membranes where they support a vari-
ety of functions essential for life. It is becoming clear
that the lipid composition in cells is tightly regulated
and here the membrane contacts must function as a
coordinated whole to monitor and adjust lipid transport
so that different cell membranes maintain their function-
al composition. One reason for this tight regulation is
that cell membranes have evolved material properties
that allow them to sub-compartmentalize the bilayer
into dynamic cholesterol-stabilized sphingolipid-protein
assemblies that function in membrane trafficking, signal-
ing, and other membrane functions. This capability is a
property of cell membranes that are poised close to a
phase transition, enabling coalescence into subdomains,
that is, lipid composition has to be correctly and con-
stantly balanced. How are the intracellular membrane
lipid compositions regulated? Here, MCS are playing
an important role to rapidly adjust lipid compositions
of the different cellular membrane compartments
and govern their dynamic and functional needs.
Kai Simons’ team has developed a shotgun mass spec-
trometry platform that can analyze hundreds of lipids in
only a few minutes with absolute quantification. Their
data suggest that the plasma lipidome is tightly con-
trolled and seems to reflect the metabolic status of the
body. Since the lipids that they are measuring are con-
tained in the plasma lipoproteins, Kay Simons’s team
hypothesize that these extracellular lipid carriers func-
tion as a surveillance, delivery, and retrieval system
that could function generally as nanosensors to regulate
cellular lipid homeostasis.
MCS With Mitochondria
Konstanze Winklhofer (Ruhr-University Bochum,
Germany) reported her recent research on the role of ubiq-
uitination and E3 ubiquitin ligases/deubiquitinases in the
dynamic regulation of ER-mitochondria contact sites
under physiological and pathophysiological conditions.
Mike Ryan (Monash University, Australia) presented
work on knockout cell lines showing that Dynamin-
related protein 1 (Drp1) is essential for both mitochon-
drial and peroxisomal fission while the other dynamin
members play a less critical role in this process. Drp1
was shown to independently constrict and sever
preformed membrane tubules in vitro in a process
dependent on GTP hydrolysis.
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Luca Scorrano (University of Padova, Italy) pre-
sented the results of a genome-wide screening for
ER-mitochondria contact modulators. By using a
Foerster resonance energy transfer (FRET) probe, his
group screened a library containing five different
shRNAs per each of the approximately 13,000 genes
targeted. To refine the list of identified modulators,
they ran isobaric tag for relative and absolute quantita-
tion (iTRAQ) mass spectrometry on MAM samples
from brain and MEFs, in collaboration with Ivan
Dikic’s group (Goethe University, Germany). The inter-
section of the two lists was further curated to identify
potential tethers and spacers. Subscreening identified
three previously uncharacterized ER-mitochondria con-
tact modulators. Interestingly, most of these modulators
are involved in disease and are alternatively spliced in
variants targeted on the two opposing membranes.
Thomas Langer (CECAD, University of Cologne,
Germany) reported research on membrane contacts
that facilitate lipid transport between the mitochondrial
outer and inner membranes, which is facilitated by lipid
transfer proteins of the Ups/PRELI family. These con-
served proteins exhibit high lipid specificity whose struc-
tural basis is not understood. Combining new X-ray
structures with gain-of-function genetic screens in
yeast, his work demonstrates that head group recogni-
tion and flexible loop regions regulating lipid binding
confer specificity to lipid transfer proteins of the Ups/
PRELI family.
Anne Hamacher-Brady (Johns Hopkins University,
USA) discussed findings on direct interactions between
mitochondria and endosomes/lysosomes during apoptosis
signaling. Quantitative, high-resolution live cell fluores-
cence microscopy revealed that mitochondria are globally
and dynamically targeted by endosomes/lysosomes during
apoptosis-related mitochondrial membrane permeabiliza-
tion. Molecular dissection and perturbation strategies indi-
cate a regulatory role of these interorganelle interactions
on functional mitochondrial apoptosis signaling.
Tito Cali (University of Padova, Italy) presented an
extended palette of split green fluorescent protein-based
MCS sensors (SPLICS) for in vitro and in vivo narrow
and wide heterotypic MCS monitoring. An improved
single-vector-based SPLICS probe (SPLICSS/L-P2A)
revealed the dynamic nature of the ER-mitochondria
interface under basal conditions and upon cell stimula-
tion, in vivo. A novel YFP-based single-vector SPLICS
probe (PM-SPLICSS/L-P2A) to monitor changes in the
ER-PM interface was also discussed. The extended pal-
ette of SPLICS probes could allow for simultaneous
MCS and diseases (metabolic, 
cancer, neurodegeneration)
MCS with mitochondria MCS with the ER
Calcium signalling at MCS
Redox at MCSLipid metabolism at MCS
MCS with the late secretory 
pathway and the PM
mito
ER
LD
LD
LD
Perox
Perox
Perox
LE/Lys
LE/Lys
LE/Lys
LE Phag
TGN ER ER
ER
mito
mito
mito
ER
PM PM
PM
PM
Nucleus
Perox
RER
Nucleus
Figure 1. Schematic cartoon illustrating select mammalian interorganellar MCS and related functions. ER¼ endoplasmic reticulum;
mito¼mitochondria; LE¼ late endosomes; Lys¼ lysosomes; Perox¼ peroxisomes; LD¼ lipid droplets; PM¼ plasma membrane;
Phag¼ phagosome; TGN¼ trans-Golgi network; RER¼ rough endoplasmic reticulum.
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monitoring of the ER-mitochondria and the ER-PM
contacts within the same cell.
MCS With the ER
Luca Pellegrini (Laval University, Canada) presented
the first in vivo structural and functional characteriza-
tion of a new cellular compartment, which he christened
WrappER. Using electron tomography and 3D recon-
struction analysis, he showed that the WrappER is com-
posed by rough-ER that extensively wraps around most
of the mitochondria and of the peroxisomes of the
mouse liver hepatocyte. Using unbiased parallel proteo-
mic, transcriptomic, and lipidomics analysis on isolated
mouse liver WrappER, he showed that this new type of
ER is functionally linked to lipoprotein biogenesis.
Maria Livia Sassano (Patricia Agostinis lab; KU
Leuven, Belgium) reported on work unraveling that
the ER stress sensor PERK interacts with the lipid bind-
ing and trafficking protein Extended synaptotagmin 1
(E-Syt1), which they found enriched at MAM. PERK-
E-Syt1 interaction occurs at ER-mitochondria contacts.
Through loss-of function studies coupled to subcellular
lipidomics, they found that PERK and E-Syt1 remodel
the ER-mitochondria phospholipids redistribution.
Ivan Robert Nabi (University of British Columbia,
Canada) presented work on the role of the ER-
associated protein degradation (ERAD)-associated
Gp78 E3 ubiquitin ligase in the regulation of rough
ER-mitochondria contacts and mitophagy. Data were
presented showing that Gp78 induced mitophagy of
both undamaged and damaged mitochondria.
Maya Schuldiner (Weizmann Institute of Science,
Israel) described the recent efforts of her lab to map
the proteome of all yeast contact sites by systematic
colocalization assays. To do this, they have taken split
Venus fluorophore sensors of many different MCS and
have colocalized their signal with thousands of yeast
proteins tagged with a red-fluorophore. For each
MCS, they have discovered a myriad of new proteins,
many of which have unknown functions and have never
before been studied. Among those are new members of a
family of lipid transfer proteins that are distributed
amongst multiple cellular contacts.
Pietro De Camilli (Yale University, USA) focused on
VPS13, a very large protein encoded by four genes in
humans. He reported that VPS13 is a lipid transport
protein that contains a very large hydrophobic cavity
in its N-terminal region. VPS13A and VPS13C localize
at contacts of the ER with mitochondria and lysosomes,
respectively, but both proteins also localize at ER-lipid
droplet contacts. Loss-of-function mutations of VPS13A
and VPS13C result in chorea-acanthocytosis and
Parkinson’s disease, respectively, suggesting that these
neurodegenerative conditions are due to defects in
interorganelle lipid transport. Most interestingly,
VPS13 has homology to the autophagy protein ATG2,
pointing to a lipid transport function of this protein
as well.
Ruben Fernandez-Busnadiego (MaxPlanck Institute of
Biochemistry, Germany) uses cryo-electron tomography
to understand the molecular organization of MCS. His
team showed how some of the tethers of ER-PM MCS
are involved in generating high curvature on the ERmem-
brane to presumably facilitate lipid transport to the PM.
Julien Prudent (University of Cambridge, UK)
emphasized the new role of phosphatidylinositol-4-
phosphate (PI(4)P) in the late stage of mitochondrial
division. His work showed that PI(4)P, generated by
phosphatidylinositol 4-kinase IIIb, the effector of the
small GTPase Arf1, accumulates at ER-mitochondria
MCS and is required for mitochondrial fission, down-
stream of Drp1 recruitment.
Peroxisomes and Redox at MCS
Gy€orgy Hajnoczky (Thomas Jefferson University, USA)
discussed the structure and signaling function of the
ER-mitochondria MCS. He described the development
of synthetic interorganellar linkers for the measurement
and perturbation of the physical parameters and
Ca2þand reactive oxygen species (ROS) signaling func-
tions of these contacts. Lastly, he showed propagation of
mitochondrial ROS production to the adjoining ER for
stimulation of ER Ca2þ mobilization.
Michael Schrader (University of Exeter, UK) talked
about peroxisome-ER MCS. His group showed that
ACBD5, a peroxisomal acyl-CoA binding membrane
protein, directly interacts with ER-resident VAPB and
regulates peroxisome-ER interactions. First patients
with ACBD5 deficiency have been identified, who pre-
sent with white matter disease, ataxia, and retinal dys-
trophy. Loss of ACBD5, which combines tethering and
fatty acid capturing properties, has metabolic conse-
quences for peroxisome-ER cooperation in ether lipid
(myelin) biosynthesis and metabolism of very long-
chain fatty acids. In addition, it impacts on phospholipid
transfer from ER to peroxisomes for peroxisomal mem-
brane expansion, on peroxisome positioning and move-
ment within the cell.
Peter Kim (Hospital for Sick Children, University of
Toronto, Canada) reported on the role of the oxysterol-
binding protein-related proteins (ORPs), which are
involved in the trafficking of cholesterol and other
lipids, at peroxisomal MCS, a still largely unexplored
field. An siRNA screen of all 12 ORPs revealed a
novel role of a number of ORPs in peroxisomes biogen-
esis and function.
Gy€orgy Csordas (Thomas Jefferson University, USA)
reported on studies of the effect of the environmental
4 Contact 0(0)
pollutant arsenic (As(III)) on local Ca2þ and ROS com-
munication at ER MCS. They found ROS-dependent
killing of hepatocytes involved enhanced local ER-to-
mitochondria Ca2þ transfer (required IP3Rs and
MCU) despite suppressed IP3R-mediated Ca2þ release,
owing to ER MCS tightening and mitochondrial Ca2þ
uptake sensitization.
Barbara Knoblach (Richard Rachubinski lab;
University of Alberta, Canada) described work on
yeast Pex3p, a membrane protein of peroxisomes and
ER, and Inp1p, a connector linking peroxisomes to the
ER. They defined regions in Inp1p required for tether
assembly and maintenance and showed that proteins
that interact with Inp1p, but localize primarily outside
of ER-peroxisome tethers, affect peroxisome dynamics.
Their findings suggest the presence of regulatory cues
acting on ER-peroxisome tethers and the existence of
MCS between peroxisomes and organelles other than
the ER.
Lipid Metabolism and Roles at MCS
Tim Levine (UCL Institute of Opthalmology, UK) iden-
tified widespread tubular lipid transfer domains
(TULIPs) in bacteria, some of which share an N-termi-
nal hydrophobic scoop with TamB, implicating TamB in
lipid traffic to the bacterial outer membrane. His team
has also attempted to map all potential FFAT-like
motifs in yeast.
Will Prinz (NIH, NIDDK, USA) showed that lipid
droplet and peroxisome biogenesis can occur at the same
domains in the ER. These domains are marked by pro-
teins that contain reticulon-like domains, Pex30 in yeast
and MCTP2 in mammals. The Pex30/MCTP2 ER
domains often remain associated with mature lipid drop-
lets and peroxisomes, suggesting an unexpected link
between organelle biogenesis in the ER and subsequent
contacts between the ER and organelles that form there.
Mark McNiven (Mayo Clinic, USA) presented obser-
vations focused on the catabolism of cytoplasmic lipid
droplets in hepatocytes, a central fat storing cell in the
body. Digital recordings of live hepatocytes, and elec-
tron microscopy of fixed cells, demonstrated an active
and transient exchange of both surface proteins and
lipids from lipid droplets to lysosomes. This process
was termed nanolipophagy.
Chris Loewen’s group (University of British
Columbia, Canada) identified a pH biosensing role for
PI(4)P in the trans-Golgi network (TGN) in yeast and
showed that this regulates the recruitment of Osh1 to
ER-TGN membrane contacts. Osh1 TGN recruitment
regulates trafficking at the TGN in response to glucose
availability, a major signal regulating intracellular pH.
Thus, intracellular pH is a factor regulating protein
recruitment to membrane contacts.
Francesca Giordano (Institute for Integrative Biology
of the Cell, France) presented work on the identification
of the oxysterol binding protein (OSBP)-related proteins
ORP5 and ORP8 as the lipid transport machinery medi-
ating phosphatidylserine transport at ER-mitochondria
MCS. They have also found that ORP5/8 are physically
and functionally linked to the components of the
MICOS complex that bridge outer and inner mitochon-
drial membranes to increase the efficiency of lipid trans-
port between ER and mitochondria.
Robin Klemm (University of Zurich, Switzerland)
presented the discovery of a mechanism that controls
the spatial organization of organelles during adipocyte
differentiation. His group found that the outer mito-
chondrial membrane protein MIGA2 tethers mitochon-
dria to the ER and lipid droplets and this is important
for efficient de novo biosynthesis of triacylglycerols from
nonlipid precursors. Lipid droplets are formed during
starvation, likely to prevent lipotoxicity by excess fatty
acids formed upon autophagic degradation.
Mitsuo Tagaya (Tokyo University of Pharmacy and
Life Sciences, Japan) reported that in addition to auto-
phagosome formation, Syntaxin 17 mediates lipid drop-
let formation by interacting with acyl-CoA synthetase 3,
a critical enzyme for lipid droplet formation.
Carmelina Petrungaro (Benoı̂t Kornmann lab; ETH
Zurich, Switzerland) presented a new strategy to moni-
tor phospholipid transport in vivo using an enzyme-
mediated lipid modification approach. This method ena-
bles for the first time the analysis of distinct transport
routes between organelles of choice.
Calcium Signaling at MCS
Franck Polleux’s group (Columbia University, USA)
recently identified PDZD8 as an ER protein present at
ER-mitochondria MCS and showed using gene replace-
ment strategies in yeast that its SMP domain is function-
ally related to the SMP domain found in yeast Mmm1.
Using 3D FIB-SEM in a Pdzd8 knockout cell line, they
found that PDZD8 is required for the formation of ER-
mitochondria contacts. In cortical pyramidal neurons,
PDZD8 is required for Ca2þ uptake by mitochondria
following synaptically induced Ca2þ-release from the
ER and thereby regulates cytoplasmic Ca2þ dynamics
in dendrites of pyramidal neurons in vitro. These results
identify PDZD8 as a novel ER-mitochondria tethering
protein in metazoan cells and uncover a critical role for
ER-mitochondria coupling in the regulation of dendritic
Ca2þ dynamics in mammalian neurons.
Paola Pizzo (University of Padova, Italy) found
two unsuspected proteins, known to participate in
different cellular processes, to be enriched at the
ER-mitochondria interface and able to modulate their
functional crosstalk. The first one, the TOM70
Bayer et al. 5
component of the mitochondrial translocase of the outer
membrane, binds and recruits IP3Rs at ER-
mitochondria contact sites, sustaining interorganelle
Ca2þ transfer, mitochondrial respiration, and ATP pro-
duction in a translocase-independent way. Similarly, the
ER protein Presenilin-2 (PS2), especially its mutant
forms linked to familial Alzheimer’s disease (FAD), is
also able, independently from its gamma secretase activ-
ity, to modulate mitochondrial function and bioenerget-
ics, by a different mechanism: FAD-PS2 decreases both
ER Ca2þ content, and thus, the amount of Ca2þ taken
up by mitochondria upon physiological stimulations,
and Hexokinase I mitochondrial association, altering
organelle metabolites availability.
MCS With the Late Secretory Pathway
and PM
Elizabeth Conibear’s group (University of British
Columbia, Canada) identified two adaptor proteins
that recruit yeast Vps13 to different membrane contacts
and showed that all known adaptors bind Vps13 via a
related motif. These results support a competition-based
model for regulating the dynamic localization of Vps13.
Efficient cross-presentation of phagocytosed antigens
is vital for anti-cancer immunity and requires ER pro-
teins, yet its mechanisms remain poorly understood.
Paula Nunes-Hasler (University of Geneva,
Switzerland) described a novel mechanism regulating
cross-presentation where the ER-SNARE protein
Sec22b tethers ER-phagosome MCS, facilitating PI(4)
P/PS exchange.
Christian Ungermann (University of Osnabrueck,
Germany) showed recent progress on the constituents
and function of vacuole and mitochondria patch
(vCLAMP) contact sites. He showed that the vacuolar
HOPS subunit Vps39 and the mitochondrial outer mem-
brane protein Tom40 form the principle tether of this
contact site. Furthermore, his group identified
separation-of-function alleles in both proteins that spe-
cifically impaired vCLAMPs, while maintaining their
additional function on mitochondria and vacuoles.
Based on this, he showed that vCLAMPs are critical
for growth and proliferation of yeast cells.
MCS and Metabolic Diseases
Cancer cells dying in response to immunogenic cell death
(ICD) stimulate anti-tumor immunity. Patrizia
Agostinis’ group (KU Leuven, Belgium) unraveled that
during ICD, the extracellular exposure/emission of key
danger signals by the dying cancer cells requires a
PERK-Filamin A axis. This PERK-mediated module
governs the spatial organization of ER-PM appositions
and store operated Ca2þ entry, through the dynamic
rearrangement of the cytoskeleton.
Proper coordination of metabolism and its integra-
tion with immune response is paramount for the func-
tion and survival of cells. Gokhan Hotamisligil’s group
(Harvard University, Harvard-MIT Broad Institute,
USA) in the past decade uncovered a critical role for
the ER in this coordinated response and metabolic adap-
tation and in the pathogenesis of metabolic diseases such
as obesity and diabetes. This new role of the ER involves
specialized molecules involved in metabolic adaptation
as well as interactions with other organelles, particularly
the contacts between the ER and mitochondria. The
details of these interactions during nutrient fluctuations
and under obesity, and the application of advanced
imaging technologies to quantitatively document these
complex interactions were discussed. In conclusion,
ER-mitochondria interactions were found to be highly
dynamic and dramatically regulated during feeding
cycles and disrupted in obesity in the liver tissue.
Emine Korkmaz (FEI/Thermo, The Netherlands)
presented an integrated Cryo-Tomography Workflow
aiming at determining structures directly within cellular
environments.
MCS and Cancer
Anti-apoptotic Bcl-2-family members, including Bcl-2
and Bcl-XL, reside at ER-MCS, thereby directly target-
ing IP3Rs and VDAC1, both Ca2þ-transport systems.
Geert Bultynck (KU Leuven, Belgium) discussed work
identifying the molecular determinants underlying IP3R/
Bcl-2-complex formation, pointing to a unique role for
Bcl-2’s BH4 domain. This work also yielded novel pep-
tide tools that can either antagonize or mimic Bcl-2’s
function in IP3R modulation. Bcl-2-inhibiting peptides
targeting Bcl-2’s BH4 domain are able to elicit pro-
apoptotic Ca2þ signals in a variety of Bcl-2-dependent
cancer cell models, causing cell death. Bcl-2-derived pep-
tides corresponding to its BH4 domain are able to pre-
vent pathophysiological Ca2þ signals that underlie
disease burden in models of acute pancreatitis.
David Bernard (Université de Lyon, France) pre-
sented the work of his laboratory showing that ITPR2
(also known as IP3R2) promotes cellular senescence
through increased levels of mitochondrial Ca2þ. They
now reveal that ITPR2 plays a role in regulating
cancer, some other aging hallmarks and lifespan in
mice, and this could be linked to MERCs and cellu-
lar senescence.
Michelangelo Campanella’s group (The Royal
Veterinary College, University of London, UK) discov-
ered that stressed mitochondria gather on the nucleus
establishing cholesterol-rich contact sites to facilitate
the retrograde response. This first evidence of tethering
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between mitochondria and nucleus is regulated by the
outer mitochondrial membrane-based protein TSPO
and implicated in aggressive forms of breast cancer.
Nina Bonekamp (Nils-G€oran Larsson lab; Max
Planck Institute for Biology of Ageing, Germany) pre-
sented recent work on specific inhibitors of the mito-
chondrial RNA polymerase. Treatment of certain
tumor cell lines with the inhibitors led to a reduction
of cancer cell proliferation in vitro as well as in vivo
without acute toxicity.
MCS and Neurodegeneration
Estela Area Gomes (Columbia University, USA) pre-
sented work showing that the 99 aa C-terminal domain
of the amyloid precursor protein (APP-C99), a protein
associated to Alzheimer’s disease (AD), is involved in the
regulation of MAM activity. In AD, the accumulation of
APP-C99 at the MAM alters MAM function in the reg-
ulation of lipid homeostasis and mitochondrial function-
ality. This work suggests that lipid deregulation is an
early feature of AD triggered by MAM dysfunction.
The TMEM16 family of proteins have recently been
identified as evolutionarily conserved but functionally
diverse modulators of cellular physiology and human
pathology. While their yeast homolog Ist2 was shown
to act as an MCS tether, no such function was attributed
to mammalian counterparts. Maja Petkovich (Lily and
Yuh-Nung Jan lab; University of California San
Francisco, USA) showed that the spinocerebellar
ataxia gene TMEM16K acts at ER-endolysosomal con-
tact sites and is essential for proper endolysosomal func-
tion, opening the possibility that physiological functions
of this important family of proteins in mammals are
linked with interorganelle communication.
Julien Licchesi (University of Bath, UK) discussed
preliminary data regarding the identification of a novel
E3 ubiquitin ligase at MAM in brain cells. Moreover, his
data suggest that MAM are dynamic microenvironments
where the ubiquitin system might have important regu-
latory functions.
Yannik Poirier (Anne Eckert’s lab; Psychiatric
University Clinics Basel, University of Basel, Switzerland)
presented that amyloid-b and tau-overexpressing cells have
a highly activated unfolded protein response (UPR) and
dysregulated mitochondrial bioenergetics, phenotypes
which were found to increase upon an additional ER
stress. These findings lend further evidence for the interplay
between the UPR of the ER and mitochondrial dysregu-
lation and provide new insights into the diverse pathways
involved in AD pathology.
Poster Prize Winners
The winners of the Poster Sessions were as follows: Rishi
Agrawal (Columbia University, USA), Yves Gouriou
(INSERM U1060, France), and Florian Dingreville
(University of Lyon, France). The Neuroscience
Award (funded by Dementia Discovery Fund) was
won by Elizabeth Sun (Yale University, USA).
Rishi Agrawal observed increased functionality of
MAM-localized lipid biosynthetic enzymes in a mouse
model of traumatic brain injury, possibly as a mecha-
nism for repairing damaged membranes; these findings
recapitulate their previous work in AD and suggest
a molecular link between traumatic brain injury and
AD. Yves Gouriou showed that MFN2 knock-down is
associated with a Warburg-like mechanism increasing
the glycolytic metabolism and the cytosolic ATP impor-
tation into mitochondria through ANT2. This study
suggested that this metabolic reprogramming confers
resistance to hypoxic injury. Florian Dingreville demon-
strated that glucotoxicity-associated beta cell dysfunc-
tion is associated with increased ER-mitochondria
interactions, disruption of Ca2þ homeostasis, and mito-
chondria fission in rat and human pancreatic beta cells.
Elizabeth Sun reported on TMEM24 (CDCD2L), a lipid
transfer protein predominantly expressed in neurons and
neuroendocrine cells. TMEM24 functions as a tether
between the ER and the PM, resides near Kv2.1 chan-
nels, and is regulated by cytosolic Ca2þ.
Concluding Remarks
On behalf of the MCS community, we would like to
thank Thomas Simmen and his co-organizers Jennifer
Rieusset, Antonio Zorzano, and Stephan Frank, for
securing the funding and the organization of a truly
inspiring and highly educating scientific meeting. The
MCS community gathered in Arosa elected the authors
of this report to carry the torch and organize a new
edition of this EMBO Workshop in 2020.
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